Cerebellum’s Abbott ABT Stock Holding History

Cerebellum’s Portfolio ABT Stock Details ABT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	$67K	Sell	614 -1,716	-74%	-$174K	0.31%	6
2020 Q2	$133K	Buy	+2,330	New	+$211K	0.09%	71
2018 Q2	–	Sell	-3,148	Closed	-$189K	–	405
2018 Q1	$189K	Buy	3,148 +818	+35%	+$49.3K	0.24%	123
2017 Q4	$133K	Buy	+2,330	New	+$129K	0.09%	71

Other funds holding ABT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Cerebellum's ABT Position: Q3 2020 in Review

Cerebellum reduced its Abbott (ABT) stake by 74% in Q3 2020, selling an estimated $174K and leaving 614 shares worth $67K. The position accounts for 0.31% of the portfolio, ranked #6.

Cerebellum first reported a position in ABT in Q4 2017 and has held it in 4 quarters since. The position peaked at $189K in Q1 2018. 2,306 funds tracked by Wall St. Rank hold ABT as of Q3 2020.

Cerebellum held 614 shares of Abbott worth $67K as of Q3 2020.
Cerebellum sold 1,716 Abbott shares in Q3 2020, an estimated $174K.
Abbott made up 0.31% of Cerebellum's portfolio in Q3 2020, its #6 holding.
Cerebellum first reported a position in Abbott in Q4 2017 and has held it in 4 quarters since.
Cerebellum's Abbott position peaked at $189K in Q1 2018.
2,306 funds tracked by Wall St. Rank held Abbott as of Q3 2020.

Based on Cerebellum's 13F filing for Q3 2020, filed 21 Oct 2020.